The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease.
about
Calcium regulation and bone mineral metabolism in elderly patients with chronic kidney diseaseEvolution of Cardiovascular Disease During the Transition to End-Stage Renal Disease.Changes in vitamin D-related mineral metabolism after induction with anti-tumor necrosis factor-α therapy in Crohn's disease.Vitamin D - effects on skeletal and extraskeletal health and the need for supplementation.Vitamin D bioavailability and catabolism in pediatric chronic kidney disease.Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials.Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease eventsCorrection of Low Vitamin D Improves Fatigue: Effect of Correction of Low Vitamin D in Fatigue Study (EViDiF Study)Activation of FGF-23 mediated vitamin D degradative pathways by cholecalciferol.Decreased conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKDEfficacy and safety of body weight-adapted oral cholecalciferol substitution in dialysis patients with vitamin D deficiency.Serum 25-hydroxyvitamin D level and kidney function decline in a Swiss general adult population.Phosphocalcic Markers and Calcification Propensity for Assessment of Interstitial Fibrosis and Vascular Lesions in Kidney Allograft Recipients.A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation.24,25-Dihydroxyvitamin d3 and vitamin D status of community-dwelling black and white Americans.Paricalcitol does not improve glucose metabolism in patients with stage 3-4 chronic kidney disease.Circulating vitamin D metabolites and kidney disease in type 1 diabetes.Chemotyping the distribution of vitamin D metabolites in human serum.Impaired vitamin D metabolism in CKDMineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease.Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: the Multi-Ethnic Study of Atherosclerosis.Circulating vitamin D metabolites and subclinical atherosclerosis in type 1 diabetesGenetic, Environmental, and Disease-Associated Correlates of Vitamin D Status in Children with CKD.Influence of estrogen therapy on calcium, phosphorus, and other regulatory hormones in postmenopausal women: the MESA study.Chronic Kidney Disease Alters Vitamin A Homeostasis via Effects on Hepatic RBP4 Protein Expression and Metabolic Enzymes.Analytical considerations for the biochemical assessment of vitamin D status.Analysis of vitamin D metabolic markers by mass spectrometry: current techniques, limitations of the "gold standard" method, and anticipated future directions.Controversy and consensus regarding vitamin D: Recent methodological changes and the risks and benefits of vitamin D supplementation.Calcifediol to Treat Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease.Kidney function is associated with an altered protein composition of high-density lipoprotein.Fibroblast Growth Factor 23 and the Risk of Infection-Related Hospitalization in Older Adults.The 24,25 to 25-hydroxyvitamin D ratio and fracture risk in older adults: The cardiovascular health study.Measurement of Vitamin D for Epidemiologic and Clinical Research: Shining Light on a Complex Decision.Effects of Vitamin D2 Supplementation on Vitamin D3 Metabolism in Health and CKD.The vitamin D metabolite ratio (VMR) as a predictor of functional biomarkers of bone health.Recalibration of 24,25-Dihydroxyvitamin D3 Results Based on NIST Standard Reference Material 972a.Fibroblast Growth Factor 23 Regulation by Systemic and Local Osteoblast-Synthesized 1,25-Dihydroxyvitamin D.Growth Differentiation Factor-15 and Risk of CKD Progression.
P2860
Q26863412-E52942A7-1D7F-4306-BF90-D6595F630A1DQ30234797-7C628B7F-A8CF-46F0-A8C5-214F77F60703Q30393774-C8D890A0-3CF7-41F0-978F-B1F93A323043Q30425759-4387D884-ADE7-4C37-990A-611B70E9EEB0Q33739722-A71DF3B1-C0E3-4A20-B85D-3233950DB44BQ33954224-0BA818E2-C76C-4E74-BA68-1CAC16143D79Q34114912-E553A4AC-9BCB-4DB1-A052-1AE44BEC4DA3Q34153372-1D33C264-9EBF-4CA7-B05C-6E251C99F938Q34284745-FA859480-6C85-40A9-836E-0D56E7BF7737Q34455184-BD53AD00-2BBD-47EA-95EF-97C597119A10Q35735678-AFD2118D-3815-44F6-8EB2-7A48DDE1BB46Q35817002-1B76A215-A028-47B1-AB61-81C22107449AQ36236289-B37B4CB6-DBA0-47B5-8B87-00304E45BAE0Q36381365-21F08BE6-EBAB-4B67-B980-ABA51451C546Q36390764-2F847CCA-B9D0-4A66-B011-C6C0EDFBAE94Q36431285-C6D98F24-8B1C-429C-BADF-EB3A8A6E0B37Q36442470-B145EEE0-F608-49AA-A1DC-CB243E47B8C6Q36569719-1C275685-3CDB-479D-8573-1926D0AF52E8Q36668070-EBB2E3DF-BD9D-4D6F-AF6F-EAA7F2D0A752Q36817218-3F7FB687-C02D-4941-8624-DA3D4E83580AQ36840607-39AE0A0C-C90F-4E3F-9A1C-C3F4C9459D72Q37022548-CDADB875-0FFA-4E4C-804F-368EB2933464Q37069988-75DAAC64-DF53-49E7-A93B-0C51276AAA09Q37361808-7BAB05BE-E7CF-449B-88B3-1843EC5301E7Q37701154-13F41D8B-8688-4FFB-8342-1C34E7C9B52FQ37722771-B5735A90-B80E-4CB6-A5F9-B3F9BEBE3623Q38169562-B39F3E07-F684-47E7-8BA2-210DFAF0B176Q38588203-11A6D8F7-85F0-417A-86CA-A6248F093E57Q38605841-50946961-EADD-4927-BB6A-79019D9D1AB5Q38650168-47640CE6-AAEE-4767-953B-2A2B2C3F4173Q38998962-95AB8550-D08D-41E6-9AD3-541F5825C31CQ46031816-5A49F00A-54DB-4263-9B6B-BA3FDE067632Q47666967-99A6DFF1-E160-4E9F-8F9E-C9053E26809FQ47808500-5D147E45-10EE-4B5E-BC53-DA340F11FE75Q48174318-1AB4B0FA-5541-4038-BE7E-CFEC1CF1DC7EQ49465852-9D26BF21-0A3F-41DC-8DB1-27F7173DC14CQ50347097-6065E5A4-F8AE-45B5-AA6F-93C3F9617141Q51153601-35BF4BB5-FB95-4F4B-820F-8FE30592692A
P2860
The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The serum 24,25-dihydroxyvitam ...... ced in chronic kidney disease.
@ast
The serum 24,25-dihydroxyvitam ...... ced in chronic kidney disease.
@en
type
label
The serum 24,25-dihydroxyvitam ...... ced in chronic kidney disease.
@ast
The serum 24,25-dihydroxyvitam ...... ced in chronic kidney disease.
@en
prefLabel
The serum 24,25-dihydroxyvitam ...... ced in chronic kidney disease.
@ast
The serum 24,25-dihydroxyvitam ...... ced in chronic kidney disease.
@en
P2093
P2860
P50
P356
P1433
P1476
The serum 24,25-dihydroxyvitam ...... ced in chronic kidney disease.
@en
P2093
Bessie Young
Cortney R Bosworth
Gregory Levin
Ian H de Boer
John Ruzinski
Jonathan Himmelfarb
P2860
P2888
P304
P356
10.1038/KI.2012.193
P407
P577
2012-05-30T00:00:00Z
P5875
P6179
1005471600